Santhera Pharmaceuticals Holding (SPHDF)
OTHER OTC:SPHDF

Santhera Pharmaceuticals Holding (SPHDF) Technical Analysis

31 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
12Bullish
1Neutral
2Bearish
Technical Analysis Consensus
Buy
2Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
1Neutral
1Bearish
Santhera Pharmaceuticals Holding’s (SPHDF) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Santhera Pharmaceuticals Holding is a Buy.
Santhera Pharmaceuticals Holding’s (SPHDF) 20-Day exponential moving average is 11.70, while Santhera Pharmaceuticals Holding’s (SPHDF) share price is $11.7, making it a Buy.
Santhera Pharmaceuticals Holding’s (SPHDF) 50-Day exponential moving average is 11.70, while Santhera Pharmaceuticals Holding’s (SPHDF) share price is $11.7, making it a Buy.

Santhera Pharmaceuticals Holding (SPHDF) Pivot Points

Jul 25, 2024, 05:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
11.70
11.70
11.70
11.70
11.70
11.70
11.70
Fibonacci
11.70
11.70
11.70
11.70
11.70
11.70
11.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Santhera Pharmaceuticals Holding (SPHDF) Moving Averages

Jul 25, 2024, 05:04 AM
Period
Simple
Exponential
MA5
11.70Neutral
11.70Buy
MA10
11.70Buy
11.70Buy
MA20
11.70Buy
11.70Buy
MA50
11.70Sell
11.70Buy
MA100
11.69Buy
11.55Buy
MA200
11.57Buy
10.89Buy
Santhera Pharmaceuticals Holding’s (SPHDF) 10-Day exponential moving average is 11.70, while Santhera Pharmaceuticals Holding’s (SPHDF) share price is $11.7, making it a Buy.
Santhera Pharmaceuticals Holding’s (SPHDF) 100-Day exponential moving average is 11.55, while Santhera Pharmaceuticals Holding’s (SPHDF) share price is $11.7, making it a Buy.
Santhera Pharmaceuticals Holding’s (SPHDF) stock price is $11.7 and Santhera Pharmaceuticals Holding’s (SPHDF) 50-day simple moving average is 11.70, creating a Sell signal.
Santhera Pharmaceuticals Holding’s (SPHDF) stock price is $11.7 and Santhera Pharmaceuticals Holding’s (SPHDF) 100-day simple moving average is 11.69, creating a Buy signal.
Santhera Pharmaceuticals Holding’s (SPHDF) stock price is $11.7 and Santhera Pharmaceuticals Holding’s (SPHDF) 200-day simple moving average is 11.57, creating a Buy signal.

Santhera Pharmaceuticals Holding (SPHDF) Technical Indicators

Jul 25, 2024, 05:04 AM
Name
Value
Implied Action
RSI (14)
73.98
Sell
STOCH (9,6)
0.00
-
STOCHRSI (14)
0.00
-
MACD (12,26)
<0.01
Buy
CCI (14)
0.00
-
ATR (14)
<0.01
-
ROC
0.00
-
Bull/Bear Power (13)
<0.01
Buy
Santhera Pharmaceuticals Holding’s (SPHDF) Relative Strength Index (RSI) is 73.98, creating a Sell signal.

FAQ

Is SPHDF a Buy, Hold, or Sell?
Based on SPHDF’s technical indicators, SPHDF is a Strong Buy.
    What is SPHDF’s RSI (14)?
    SPHDF’s RSI (14) is 73.98, which suggests SPHDF is a Sell.
      What is SPHDF’s MACD?
      SPHDF’s MACD is <0.01, which suggests SPHDF is a Buy.
        What is SPHDF’s 5-day moving average?
        SPHDF’s 5-day moving average is 11.70, which suggests SPHDF is a Neutral.
          What is SPHDF’s 20-day moving average?
          SPHDF 20-day moving average is 11.70, which suggests SPHDF is a Buy.
            What is SPHDF’s 50-day moving average?
            SPHDF’s 50-day moving average is 11.70, which suggests SPHDF is a Sell.
              What is SPHDF’s 200-day moving average?
              SPHDF’s 200-day moving average is 11.57, which suggests SPHDF is a Buy.
                What is SPHDF’s Williams % R (14)?
                Currently, no data Available
                What is SPHDF’s CCI (14)?
                Currently, no data Available
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis